Recently, an unbiased proteomics analysis has identified a significant up‐regulation of the immune checkpoint inhibitor, programmed cell death 1 ligand 2 (PD‐L2), in various chemotherapy‐induced senescent cancer cells.28 The gene discussed is PDCD1LG2; the disease is cancer.